...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith A Loser Too
Reply New Message
Back To Forum List View
Zenith A Loser Too
2
RVXoldtimer
Jun 16, 2020 01:38PM
Icon president Re: Zenith A Loser Too
7
Toinv
Jun 16, 2020 03:18PM

Toinv - I agree with you except I didn't have such high expectations. I wanted what you said, just didn't expect it.

1 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply